Neutralization assays.

XS Xiaoying Shen
WB Willy M. Bogers
NY Nicole L. Yates
GF Guido Ferrari
AD Antu K. Dey
WW William T. Williams
FJ Frederick H. Jaeger
KW Kevin Wiehe
SS Sheetal Sawant
SA S. Munir Alam
CL Celia C. LaBranche
DM David C. Montefiori
LM Loic Martin
IS Indresh Srivastava
JH Jonathan Heeney
SB Susan W. Barnett
GT Georgia D. Tomaras
request Request a Protocol
ask Ask a question
Favorite

Virus neutralization assays were performed on the TZM-bl cell line, using replication-competent or pseudotyped viruses grown in human PBMC as previously described (67). Serial dilutions of serum samples were tested for neutralization of a panel of tier 1 (SHIV-SF162P4 and SHIV-1157iEL-p [replication-competent viruses]) and tier 2 (SHIV-SF162P3.5 and SHIV-89.6P.18 [pseudotyped viruses] as well as SHIV-89.6 and SHIV-1157ipd3N4 [replication-competent viruses]) SHIVs in TZM-bl cells.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A